CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: PBMs agree to display TrumpRx drug prices

RegulatoryapprovedZenbexusEntrestoPositive
AI Analysis

Summary

Bristol Myers Squibb's Zenbexus received accelerated approval and Novartis won a UK patent dispute over Entresto. The article also covers PBM agreements on drug price transparency through TrumpRx.

Outcome Details

Bristol's Zenbexus wins accelerated approval

Importance:6/10
Sentiment:
0.60
accelerated_approvalpatentpricingregulatory
Related Companies

Read the original article

Published by STAT News on August 14, 2026 3:55 PM

Read Original